Showing results (2651-2660 of 2,955) with videos related to
Sort By:
Pageof 296
Cancer Investigation|March 23, 2005
Cyclosporine A, alpha-lnterferon and interleukin-2 following chemotherapy with BCNU, DTIC, cisplatin, and tamoxifen: a phase II study in advanced melanomaLynn Feun, Angela Marini, Frederick Moffat, et al.Cancer Investigation|March 23, 2005
Oxaliplatin for pretreated patients with advanced or metastatic pancreatic cancer: a multicenter phase II studyNikolaos Androulakis, Konstantinos Syrigos, Aristidis Polyzos, et al.Cancer Investigation|March 23, 2005
Phase II study of weekly low-dose paclitaxel for relapsed and refractory non-Hodgkin's lymphoma: a Wisconsin Oncology Network StudyBrad S Kahl, Howard H Bailey, Eileen P Smith, et al.Cancer Investigation|March 23, 2005
Developing an understanding of proteomics: an introduction to biological mass spectrometryJohn Koomen, David Hawke, Ryuji KobayashiCancer Investigation|March 23, 2005
Environmental and genetic risk factors for childhood leukemia: appraising the evidencePatricia A Buffler, Marilyn L Kwan, Peggy Reynolds, et al.Cancer Investigation|January 1, 1992
Five-drug antiemetic combination for cisplatin chemotherapyK S Sridhar, A M Hussein, S Hilsenbeck, et al.Cancer Investigation|June 11, 2005
Circulating angiogenic cytokines in patients with advanced non-small cell lung cancer: correlation with treatment response and survivalArkadiusz Z Dudek, Hemchandra MahasethCancer Investigation|June 11, 2005
Cisplatin-induced ototoxicity in osteosarcoma patients: a report from the late effects surveillance systemW Stöhr, T Langer, A Kremers, et al.Cancer Investigation|June 11, 2005
A phase II study on the safety and efficacy of 5-fluorouracil, epirubicin, cyclophosphamide (FEC) followed by paclitaxel in the adjuvant treatment of breast cancerMustafa Erman, Esmen Baltali, Aziz Karaoglu, et al.Cancer Investigation|June 11, 2005
Management of cancer-related fatigueGary R Morrow, Abhay R Shelke, Joseph A Roscoe, et al.Pageof 296